skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 6,070  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Material Type:
Article
Add to My Research

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

The New England journal of medicine, 2021-04, Vol.384 (16), p.1491-1502 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2100433

Full text available

2
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Material Type:
Article
Add to My Research

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

The European respiratory journal, 2019-01, Vol.53 (1), p.1801887 [Peer Reviewed Journal]

Copyright ©ERS 2019. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright ©ERS 2019 2019 ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.01887-2018 ;PMID: 30545970

Full text available

3
Real estimates of mortality following COVID-19 infection
Material Type:
Article
Add to My Research

Real estimates of mortality following COVID-19 infection

The Lancet Infectious Diseases, 2020-07, Vol.20 (7), p.773-773 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30195-X ;PMID: 32171390

Digital Resources/Online E-Resources

4
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
Material Type:
Article
Add to My Research

CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction

Canadian journal of cardiology, 2021-04, Vol.37 (4), p.531-546 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0828-282X ;EISSN: 1916-7075 ;DOI: 10.1016/j.cjca.2021.01.017 ;PMID: 33827756

Digital Resources/Online E-Resources

5
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Material Type:
Article
Add to My Research

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

European heart journal, 2020-01, Vol.41 (3), p.407-477 [Peer Reviewed Journal]

The European Society of Cardiology 2019. All rights reserved. For permissions please email: journals.permissions@oup.com. 2019 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz425 ;PMID: 31504439

Full text available

6
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Material Type:
Article
Add to My Research

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

International Journal of Antimicrobial Agents, 2020-04 [Peer Reviewed Journal]

2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/j.ijantimicag.2020.105932

Digital Resources/Online E-Resources

7
Correlation Between 3790 Quantitative Polymerase Chain Reaction–Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates
Material Type:
Article
Add to My Research

Correlation Between 3790 Quantitative Polymerase Chain Reaction–Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates

Clinical infectious diseases, 2021-06, Vol.72 (11), p.e921-e921 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa1491

Full text available

8
The 'Digital Twin' to enable the vision of precision cardiology
Material Type:
Article
Add to My Research

The 'Digital Twin' to enable the vision of precision cardiology

European heart journal, 2020-12, Vol.41 (48), p.4556-4564 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa159 ;PMID: 32128588

Full text available

9
Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial
Material Type:
Article
Add to My Research

Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial

European journal of heart failure, 2019-10, Vol.21 (10), p.1279-1287 [Peer Reviewed Journal]

Attribution - NonCommercial ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.1596 ;PMID: 31523904

Digital Resources/Online E-Resources

10
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial
Material Type:
Article
Add to My Research

Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial

European heart journal, 2021-03, Vol.42 (13), p.1203-1212 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;Attribution - NonCommercial ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa1007 ;PMID: 33420498

Full text available

11
Antibiotic Adjuvants: Make Antibiotics Great Again
Material Type:
Article
Add to My Research

Antibiotic Adjuvants: Make Antibiotics Great Again

Journal of medicinal chemistry, 2019-10, Vol.62 (19), p.8665-8681 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0022-2623 ;EISSN: 1520-4804 ;DOI: 10.1021/acs.jmedchem.8b01781

Digital Resources/Online E-Resources

12
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
Material Type:
Article
Add to My Research

Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine

European heart journal, 2021-01, Vol.42 (2), p.152-161 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;Attribution - NonCommercial ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa736 ;PMID: 33099609

Full text available

13
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Material Type:
Article
Add to My Research

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

International journal of antimicrobial agents, 2020-05 [Peer Reviewed Journal]

Attribution - NonCommercial - NoDerivatives ;ISSN: 0924-8579 ;EISSN: 1872-7913 ;DOI: 10.1016/j.ijantimicag.2020.105938

Digital Resources/Online E-Resources

14
Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure
Material Type:
Article
Add to My Research

Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure

Journal of the American College of Cardiology, 2021-03, Vol.77 (11), p.1397-1407 [Peer Reviewed Journal]

2021 The Authors ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.01.044 ;PMID: 33736821

Full text available

15
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
Material Type:
Article
Add to My Research

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

International Journal of Antimicrobial Agents, 2020-03 [Peer Reviewed Journal]

2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/j.ijantimicag.2020.105923

Digital Resources/Online E-Resources

16
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Material Type:
Article
Add to My Research

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

International Journal of Antimicrobial Agents, 2020-07 [Peer Reviewed Journal]

2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Attribution - NonCommercial ;ISSN: 0924-8579 ;EISSN: 1872-7913 ;DOI: 10.1016/j.ijantimicag.2020.105949

Digital Resources/Online E-Resources

17
Targeting transforming growth factor-β receptors in pulmonary hypertension
Material Type:
Article
Add to My Research

Targeting transforming growth factor-β receptors in pulmonary hypertension

The European respiratory journal, 2021-02, Vol.57 (2), p.2002341 [Peer Reviewed Journal]

Copyright ©ERS 2021. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.02341-2020 ;PMID: 32817256

Full text available

18
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
Material Type:
Article
Add to My Research

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

European heart journal, 2022-02, Vol.43 (5), p.416-426 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;Attribution - NonCommercial ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehab798 ;PMID: 34878502

Full text available

19
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Material Type:
Article
Add to My Research

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

The New England journal of medicine, 2021-10, Vol.385 (16), p.1451-1461 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2107038 ;PMID: 34449189

Full text available

20
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society
Material Type:
Article
Add to My Research

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society

European journal of heart failure, 2020-11, Vol.22 (11), p.1945-1960 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.1920 ;PMID: 32463967

Digital Resources/Online E-Resources

Results 1 - 20 of 6,070  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (5,396)

Refine My Results

Creation Date 

From To
  1. Before 1990  (26)
  2. 1990 To 1997  (101)
  3. 1998 To 2005  (191)
  4. 2006 To 2014  (970)
  5. After 2014  (4,693)
  6. More options open sub menu

Language 

  1. English  (5,724)
  2. Japanese  (597)
  3. French  (357)
  4. Norwegian  (10)
  5. Portuguese  (6)
  6. Ukrainian  (4)
  7. Spanish  (4)
  8. Russian  (3)
  9. German  (2)
  10. Polish  (1)
  11. Czech  (1)
  12. More options open sub menu

Searching Remote Databases, Please Wait